Imaging Studies in Corticobasal Syndrome
NCT07000851
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cortico Basal Degeneration
- Corticobasal Syndrome
- Corticobasal Syndrome(CBS)
- Corticobasal Degeneration
- Corticobasal Degeneration (CBD)
- Corticobasal Syndrome (CBS)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Jennifer Whitwell
- Last updated on ClinicalTrials.gov
- July 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Minnesota · 1
- Mayo Clinic · Rochester, MN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.